We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 325

China’s NHFPC further strengthening its scrutiny over irregularities in the healthcare industry

  • King & Wood Mallesons
  • -
  • China
  • -
  • March 18 2014

China's National Health and Family Planning Commission(" NHFPC ") has recently stepped up its efforts to strengthen the administration of healthcare

China cracking down on pharmaceutical corruption

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • China, USA
  • -
  • March 25 2014

On December 25, 2013, the National Health and Family Planning Commission of China ("National Health Commission", former Ministry of Health) issued

Making and selling medical devices in China: what you need to know about product liability

  • Fredrikson & Byron PA
  • -
  • China, USA
  • -
  • August 3 2012

In 2009, the Chinese government committed to spend RMB 850 billion ($124 billion) to develop China’s healthcare system and improve universal healthcare access

Medical reforms should aim at preventing disease (China Daily 2012-07-24) --- July

  • Reed Smith LLP
  • -
  • China
  • -
  • August 8 2012

Government officials and experts participating in a forum organized by the Economist magazine agreed that China should focus on improving public health and preventing diseases, even as it is struggling with the ever-increasing cost of medical care

China releases Fast Track Approval Process for Innovative Medical Devices

  • Ropes & Gray LLP
  • -
  • China
  • -
  • February 12 2014

On February 7, 2014, the China Food and Drug Administration ("CFDA") promulgated a notice titled The Fast Track Approval Process for Innovative

China’s drug recall measures require 24-hour response

  • Hogan Lovells
  • -
  • China
  • -
  • March 26 2008

On December 10, 2007 the PRC’s State Food and Drug Administration (SFDA) issued the Administrative Measures for Drug Recalls (the Measures), which became effective on the same day

Chinese regulations on medical device advertisements

  • Reed Smith LLP
  • -
  • China
  • -
  • September 21 2009

Effective May 20, 2009, China’s State Administration of Industry and Commerce ("SAIC"), the Ministry of Health (MOH), and the State Food & Drug Administration ("SFDA") jointly issued "Measures for the Examination of Medical Device Advertisements" ("Measures") and "Standards for the Examination and Release of Medical Device Advertisements" ("Standards"), both of which are relevant to medical device manufacturers and distributors advertising medical devices and diagnostic products within China

FDA news

  • Drinker Biddle & Reath LLP
  • -
  • China, USA
  • -
  • April 30 2008

On 10 March, Commissioner Eschenbach announced, after a national search, the appointment of Janet Woodcock, M.D., as the new CDER Director

China’s new rules on bribery blacklisting of healthcare companies and ethics of healthcare professionals

  • Baker & McKenzie
  • -
  • China
  • -
  • January 16 2014

On 25 December 2013, the People's Republic of China National Health and Family Planning Commission ("NHFPC") issued the Regulations on Establishing a

China liberalizes foreign investment in medical services sector

  • Hogan Lovells
  • -
  • China
  • -
  • December 15 2010

On 26 November 2010, the State Council circulated the Opinions on Further Encouraging and Guiding the Use of Non-governmental Capital in the Establishment of Medical Institutions ("Opinions"